Ameriprise Financial Inc Ionis Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 397,898 shares of IONS stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
397,898
Previous 8,792 4425.68%
Holding current value
$14.1 Million
Previous $419,000 3704.06%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.06 - $51.86 $15.6 Million - $20.2 Million
389,106 Added 4425.68%
397,898 $15.9 Million
Q2 2024

Aug 14, 2024
SELL
$36.45 - $47.7 $250,812 - $328,223
-6,881 Reduced 43.9%
8,792 $419,000
Q1 2024

May 15, 2024
SELL
$42.03 - $53.55 $418,282 - $532,929
-9,952 Reduced 38.84%
15,673 $679,000
Q4 2023

Feb 14, 2024
BUY
$43.39 - $51.63 $772,775 - $919,530
17,810 Added 227.9%
25,625 $1.3 Million
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $55,632 - $68,102
-1,445 Reduced 15.6%
7,815 $354,000
Q2 2023

Aug 14, 2023
BUY
$34.73 - $43.33 $11,912 - $14,862
343 Added 3.85%
9,260 $379,000
Q1 2023

May 15, 2023
SELL
$33.58 - $41.2 $148,222 - $181,856
-4,414 Reduced 33.11%
8,917 $318,000
Q4 2022

Feb 14, 2023
SELL
$37.12 - $46.52 $941,808 - $1.18 Million
-25,372 Reduced 65.56%
13,331 $503,000
Q3 2022

Nov 14, 2022
BUY
$36.54 - $48.66 $998,236 - $1.33 Million
27,319 Added 239.98%
38,703 $1.71 Million
Q2 2022

Aug 15, 2022
SELL
$31.71 - $43.0 $41,159 - $55,814
-1,298 Reduced 10.23%
11,384 $421,000
Q1 2022

May 16, 2022
BUY
$29.88 - $37.04 $91,283 - $113,157
3,055 Added 31.73%
12,682 $467,000
Q4 2021

Feb 14, 2022
SELL
$25.61 - $35.1 $32,575 - $44,647
-1,272 Reduced 11.67%
9,627 $293,000
Q3 2021

Nov 15, 2021
BUY
$33.54 - $40.55 $32,667 - $39,495
974 Added 9.81%
10,899 $366,000
Q2 2021

Aug 16, 2021
SELL
$34.54 - $47.25 $157,260 - $215,129
-4,553 Reduced 31.45%
9,925 $395,000
Q1 2021

May 17, 2021
SELL
$42.51 - $63.78 $33,200 - $49,812
-781 Reduced 5.12%
14,478 $652,000
Q4 2020

Feb 12, 2021
BUY
$45.3 - $60.27 $215,039 - $286,101
4,747 Added 45.16%
15,259 $865,000
Q3 2020

Nov 16, 2020
SELL
$47.45 - $62.95 $25,907 - $34,370
-546 Reduced 4.94%
10,512 $498,000
Q2 2020

Aug 14, 2020
BUY
$46.85 - $61.05 $51,441 - $67,032
1,098 Added 11.02%
11,058 $653,000
Q1 2020

May 15, 2020
BUY
$41.6 - $63.4 $27,248 - $41,527
655 Added 7.04%
9,960 $472,000
Q4 2019

Feb 14, 2020
BUY
$53.85 - $65.27 $59,665 - $72,319
1,108 Added 13.52%
9,305 $563,000
Q3 2019

Nov 14, 2019
BUY
$59.06 - $72.15 $19,430 - $23,737
329 Added 4.18%
8,197 $490,000
Q2 2019

Aug 14, 2019
SELL
$62.09 - $86.14 $98,474 - $136,618
-1,586 Reduced 16.78%
7,868 $506,000
Q1 2019

May 15, 2019
BUY
$52.92 - $81.17 $14,341 - $21,997
271 Added 2.95%
9,454 $767,000
Q4 2018

Feb 14, 2019
SELL
$43.37 - $59.54 $183,151 - $251,437
-4,223 Reduced 31.5%
9,183 $497,000
Q3 2018

Nov 14, 2018
SELL
$42.88 - $53.7 $5.66 Million - $7.08 Million
-131,890 Reduced 90.77%
13,406 $692,000
Q2 2018

Aug 14, 2018
BUY
$40.53 - $50.7 $2.93 Million - $3.66 Million
72,271 Added 98.97%
145,296 $6.05 Million
Q1 2018

May 15, 2018
BUY
$44.08 - $55.05 $2.36 Million - $2.94 Million
53,490 Added 273.82%
73,025 $3.22 Million
Q4 2017

Feb 12, 2018
BUY
$50.3 - $64.39 $531,017 - $679,765
10,557 Added 117.59%
19,535 $983,000
Q3 2017

Nov 07, 2017
BUY
$45.56 - $59.57 $409,037 - $534,819
8,978
8,978 $456,000

Others Institutions Holding IONS

# of Institutions
404
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email